Sex-Specific Patterns of Cerebral Atrophy and Enlarged Perivascular Spaces in Patients with Cerebral Amyloid Angiopathy and Dementia

References

1. 1.↵
   1. Greenberg SM,
   2. Bacskai BJ,
   3. Hernandez-Guillamon M, et al

   . Cerebral amyloid angiopathy and Alzheimer disease: one peptide, two pathways. Nat Rev Neurol 2020;16:30–42 doi:10.1038/s41582-019-0281-2 pmid:31827267

   CrossRefPubMed
2. 2.↵
   1. Greenberg SM,
   2. Charidimou A

   . Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria. Stroke 2018;49:491–97 doi:10.1161/STROKEAHA.117.016990 pmid:29335334

   FREE Full Text
3. 3.↵
   1. Charidimou A,
   2. Boulouis G,
   3. Frosch MP, et al

   . The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 2022;21:714–25 doi:10.1016/S1474-4422(22)00208-3 pmid:35841910

   CrossRefPubMed
4. 4.↵
   1. Subotic A,
   2. McCreary CR,
   3. Saad F, et al

   . Cortical thickness and its association with clinical cognitive and neuroimaging markers in cerebral amyloid angiopathy. J Alzheimers Dis 2021;81:1663–71 doi:10.3233/JAD-210138 pmid:33998545

   CrossRefPubMed
5. 5.↵
   1. Fotiadis P,
   2. van Rooden S,
   3. van der Grond J, et al

   ; Alzheimer’s Disease Neuroimaging Initiative. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. Lancet Neurol 2016;15:811–19 doi:10.1016/S1474-4422(16)30030-8 pmid:27180034

   CrossRefPubMed
6. 6.↵
   1. Attems J,
   2. Jellinger KA,
   3. Lintner F

   . Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 2005;110:222–31 doi:10.1007/s00401-005-1064-y pmid:16133541

   CrossRefPubMed
7. 7.↵
   1. Pfeifer LA,
   2. White LR,
   3. Ross GW, et al

   . Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 2002;58:1629–34 doi:10.1212/wnl.58.11.1629 pmid:12058090

   CrossRefPubMed
8. 8.↵
   1. Boyle PA,
   2. Yu L,
   3. Nag S, et al

   . Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 2015;85:1930–36 doi:10.1212/WNL.0000000000002175 pmid:26537052

   Abstract/FREE Full Text
9. 9.↵
   1. Xiong L,
   2. Davidsdottir S,
   3. Reijmer YD, et al

   . Cognitive profile and its association with neuroimaging markers of non-demented cerebral amyloid angiopathy patients in a stroke unit. J Alzheimers Dis 2016;52:171–78 doi:10.3233/JAD-150890 pmid:27060947

   CrossRefPubMed
10. 10.↵
    1. Moulin S,
    2. Labreuche J,
    3. Bombois S, et al

    . Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol 2016;15:820–29 doi:10.1016/S1474-4422(16)00130-7 pmid:27133238

    CrossRefPubMed
11. 11.↵
    1. Case NF,
    2. Charlton A,
    3. Zwiers A, et al

    . Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke 2016;47:2010–16 doi:10.1161/STROKEAHA.116.012999 pmid:27338926

    Abstract/FREE Full Text
12. 12.↵
    1. Costa AS,
    2. Pinho J,
    3. Kučikienė D, et al

    . Cerebral amyloid angiopathy in amyloid-positive patients from a memory clinic cohort. J Alzheimers Dis 2021;79:1661–72 doi:10.3233/JAD-201218 pmid:33492291

    CrossRefPubMed
13. 13.↵
    1. Shinohara M,
    2. Murray ME,
    3. Frank RD, et al

    . Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease. Acta Neuropathol 2016;132:225–34 doi:10.1007/s00401-016-1580-y pmid:27179972

    CrossRefPubMed
14. 14.↵
    1. Perosa V,
    2. Oltmer J,
    3. Munting LP, et al

    . Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex. Acta Neuropathol 2022;143:331–48 doi:10.1007/s00401-021-02393-1 pmid:34928427

    CrossRefPubMed
15. 15.↵
    1. Tsai HH,
    2. Pasi M,
    3. Tsai LK, et al

    . Centrum semiovale perivascular space and amyloid deposition in spontaneous intracerebral hemorrhage. Stroke 2021;52:2356–62 doi:10.1161/STROKEAHA.120.032139 pmid:33874751

    CrossRefPubMed
16. 16.↵
    1. Bouvy WH,
    2. van Veluw SJ,
    3. Kuijf HJ, et al

    ; Utrecht Vascular Cognitive Impairment (VCI) Study Group. Microbleeds colocalize with enlarged juxtacortical perivascular spaces in amnestic mild cognitive impairment and early Alzheimer’s disease: A 7 Tesla MRI study. J Cereb Blood Flow Metab 2020;40:739–46 doi:10.1177/0271678X19838087 pmid:30890076

    CrossRefPubMed
17. 17.↵
    1. Charidimou A,
    2. Boulouis G,
    3. Pasi M, et al

    . MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 2017;88:1157–64 doi:10.1212/WNL.0000000000003746 pmid:28228568

    Abstract/FREE Full Text
18. 18.↵
    1. Charidimou A,
    2. Meegahage R,
    3. Fox Z, et al

    . Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study. J Neurol Neurosurg Psychiatry 2013;84:624–29 doi:10.1136/jnnp-2012-304434 pmid:23412074

    Abstract/FREE Full Text
19. 19.↵
    1. Albert MS,
    2. DeKosky ST,
    3. Dickson D, et al

    . The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:270–79 doi:10.1016/j.jalz.2011.03.008 pmid:21514249

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Morris JC,
    2. Edland S,
    3. Clark C, et al

    . The consortium to establish a registry for Alzheimer's disease (CERAD), Part IV: rates of cognitive change in the longitudinal assessment of probable Alzheimer’s disease. Neurology 1993;43:2457–65 doi:10.1212/wnl.43.12.2457 pmid:8255439

    Abstract/FREE Full Text
21. 21.↵
    1. Wahlund LO,
    2. Barkhof F,
    3. Fazekas F, et al

    . A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318–22 doi:10.1161/01.str.32.6.1318 pmid:11387493

    Abstract/FREE Full Text
22. 22.↵
    1. Potter GM,
    2. Chappell FM,
    3. Morris Z, et al

    . Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis 2015;39:224–31 doi:10.1159/000375153 pmid:25823458

    CrossRefPubMed
23. 23.↵
    1. Harper L,
    2. Fumagalli GG,
    3. Barkhof F, et al

    . MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain 2016;139:1211–25 doi:10.1093/brain/aww005 pmid:26936938

    CrossRefPubMed
24. 24.↵
    1. Brenowitz WD,
    2. Nelson PT,
    3. Besser LM, et al

    . Cerebral amyloid angiopathy and its co-occurrence with Alzheimer’s disease and other cerebrovascular neuropathologic changes. Neurobiol Aging 2015;36:2702–08 doi:10.1016/j.neurobiolaging.2015.06.028 pmid:26239176

    CrossRefPubMed
25. 25.↵
    1. Xiong L,
    2. Boulouis G,
    3. Charidimou A, et al

    . Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage. J Cereb Blood Flow Metab 2018;38:241–49 doi:10.1177/0271678X17700435 pmid:28318355

    CrossRefPubMed
26. 26.↵
    1. Koemans EA,
    2. Castello JP,
    3. Rasing I, et al

    . Sex differences in onset and progression of cerebral amyloid angiopathy. Stroke 2023;54:306–14 doi:10.1161/STROKEAHA.122.040823 pmid:36689586

    CrossRefPubMed
27. 27.↵
    1. Gouveia-Freitas K,
    2. Bastos-Leite AJ

    . Perivascular spaces and brain waste clearance systems: relevance for neurodegenerative and cerebrovascular pathology. Neuroradiology 2021;63:1581–97 doi:10.1007/s00234-021-02718-7 pmid:34019111

    CrossRefPubMed
28. 28.↵
    1. Jeong SH,
    2. Cha J,
    3. Park M, et al

    . Association of enlarged perivascular spaces with amyloid burden and cognitive decline in Alzheimer disease continuum. Neurology 2022 Aug 19. [Epub ahead of print] doi:10.1212/WNL.0000000000200989 pmid:35985826

    CrossRefPubMed
29. 29.↵
    1. Charidimou A,
    2. Jäger RH,
    3. Peeters A, et al

    . White matter perivascular spaces are related to cortical superficial siderosis in cerebral amyloid angiopathy. Stroke 2014;45:2930–35 doi:10.1161/STROKEAHA.114.005568 pmid:25116879

    Abstract/FREE Full Text
30. 30.↵
    1. Ingala S,
    2. van Maurik IS,
    3. Altomare D, et al

    . Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease. Eur Radiol 2022;32:7789–99 doi:10.1007/s00330-021-08503-7 pmid:35639148

    CrossRefPubMed
31. 31.↵
    1. Wahlund LO,
    2. Julin P,
    3. Johansson SE, et al

    . Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 2000;69:630–35 doi:10.1136/jnnp.69.5.630 pmid:11032615

    Abstract/FREE Full Text
32. 32.↵
    1. Ferreira D,
    2. Cavallin L,
    3. Granberg T, et al

    ; AddNeuroMed Consortium and for the Alzheimer’s Disease Neuroimaging Initiative. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition. Eur Radiol 2016;26:2597–610 doi:10.1007/s00330-015-4101-9 pmid:26560730

    CrossRefPubMed
33. 33.↵
    1. Barisano G,
    2. Lynch KM,
    3. Sibilia F, et al

    . Imaging perivascular space structure and function using brain MRI. Neuroimage 2022;257:119329 doi:10.1016/j.neuroimage.2022.119329 pmid:35609770

    CrossRefPubMed
34. 34.↵
    1. Chesebro AG,
    2. Amarante E,
    3. Lao PJ, et al

    . Automated detection of cerebral microbleeds on T2*-weighted MRI. Sci Rep 2021;11:4004 doi:10.1038/s41598-021-83607-0 pmid:33597663

    CrossRefPubMed
35. 35.↵
    1. Schmidt P,
    2. Gaser C,
    3. Arsic M, et al

    . An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage 2012;59:3774–83 doi:10.1016/j.neuroimage.2011.11.032 pmid:22119648

    CrossRefPubMed
36. 36.↵
    1. Griffanti L,
    2. Zamboni G,
    3. Khan A, et al

    . BIANCA (Brain Intensity AbNormality Classification Algorithm): a new tool for automated segmentation of white matter hyperintensities. Neuroimage 2016;141:191–205 doi:10.1016/j.neuroimage.2016.07.018 pmid:27402600

    CrossRefPubMed